Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for CV Sciences (CVSI) over the last 14 years, with Q3 2025 value amounting to -$234000.0.

  • CV Sciences' Cash from Financing Activities fell 13966.1% to -$234000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$256000.0, marking a year-over-year decrease of 18231.51%. This contributed to the annual value of $32000.0 for FY2024, which is 10230.05% up from last year.
  • Latest data reveals that CV Sciences reported Cash from Financing Activities of -$234000.0 as of Q3 2025, which was down 13966.1% from -$167000.0 recorded in Q2 2025.
  • In the past 5 years, CV Sciences' Cash from Financing Activities registered a high of $2.9 million during Q1 2021, and its lowest value of -$872000.0 during Q1 2023.
  • Its 5-year average for Cash from Financing Activities is $221631.6, with a median of -$56000.0 in 2023.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first skyrocketed by 880000.0% in 2021, then plummeted by 49821.43% in 2024.
  • Over the past 5 years, CV Sciences' Cash from Financing Activities (Quarter) stood at $879000.0 in 2021, then crashed by 183.96% to -$738000.0 in 2022, then skyrocketed by 92.41% to -$56000.0 in 2023, then tumbled by 498.21% to -$335000.0 in 2024, then surged by 30.15% to -$234000.0 in 2025.
  • Its Cash from Financing Activities stands at -$234000.0 for Q3 2025, versus -$167000.0 for Q2 2025 and $480000.0 for Q1 2025.